Amedisys Inc (AMED) Social Stream
AMEDISYS INC (AMED) Price Targets From Analysts
Use the tables below to see what analysts covering AMEDISYS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 13 | $235 | $150 | $204.666 | $91.16 | 124.51% |
| 2021-12-07 | 13 | $235 | $150 | $205.5 | $91.16 | 125.43% |
| 2021-12-21 | 14 | $235 | $150 | $206.076 | $91.16 | 126.06% |
| 2022-01-06 | 14 | $230 | $150 | $203.384 | $91.16 | 123.11% |
| 2022-01-20 | 14 | $230 | $150 | $202.23 | $91.16 | 121.84% |
| 2022-02-01 | 14 | $230 | $145 | $199.461 | $91.16 | 118.8% |
| 2022-02-02 | 14 | $230 | $145 | $199.692 | $91.16 | 119.06% |
| 2022-02-17 | 14 | $230 | $147 | $197.923 | $91.16 | 117.12% |
| 2022-02-25 | 15 | $230 | $147 | $195.928 | $91.16 | 114.93% |
| 2022-03-01 | 15 | $230 | $147 | $190.357 | $91.16 | 108.82% |
| 2022-03-08 | 15 | $230 | $147 | $191.642 | $91.16 | 110.23% |
| 2022-03-24 | 15 | $230 | $160 | $192.714 | $91.16 | 111.4% |
| 2022-04-01 | 15 | $230 | $162 | $194.142 | $91.16 | 112.97% |
| 2022-04-29 | 15 | $230 | $131 | $190.785 | $91.16 | 109.29% |
| 2022-05-03 | 15 | $221 | $131 | $185.857 | $91.16 | 103.88% |
| 2022-05-26 | 15 | $221 | $131 | $183.357 | $91.16 | 101.14% |
| 2022-05-27 | 15 | $221 | $117 | $182.357 | $91.16 | 100.04% |
| 2022-06-13 | 15 | $221 | $117 | $179.357 | $91.16 | 96.75% |
| 2022-06-21 | 15 | $221 | $107 | $178.642 | $91.16 | 95.97% |
| 2022-07-14 | 16 | $221 | $102 | $164.733 | $91.16 | 80.71% |
| 2022-07-29 | 16 | $221 | $102 | $160.133 | $91.16 | 75.66% |
| 2022-08-01 | 16 | $200 | $102 | $154.866 | $91.16 | 69.88% |
| 2022-08-02 | 16 | $200 | $102 | $152.2 | $91.16 | 66.96% |
| 2022-08-03 | 16 | $200 | $95 | $146.533 | $91.16 | 60.74% |
| 2022-09-06 | 16 | $200 | $95 | $147.133 | $91.16 | 61.4% |
| 2022-09-19 | 16 | $200 | $95 | $147.933 | $91.16 | 62.28% |
| 2022-10-03 | 16 | $200 | $95 | $145.933 | $91.16 | 60.08% |
| 2022-10-05 | 16 | $200 | $95 | $145.266 | $91.16 | 59.35% |
| 2022-10-19 | 16 | $190 | $95 | $141.933 | $91.16 | 55.7% |
| 2022-10-25 | 16 | $190 | $95 | $141.266 | $91.16 | 54.96% |
| 2022-10-27 | 16 | $190 | $90 | $140.466 | $91.16 | 54.09% |
| 2022-10-28 | 16 | $190 | $90 | $135.933 | $91.16 | 49.11% |
| 2022-11-02 | 16 | $190 | $90 | $127.733 | $91.16 | 40.12% |
| 2022-11-03 | 16 | $190 | $90 | $125.785 | $91.16 | 37.98% |
| 2022-11-11 | 16 | $190 | $90 | $124.785 | $91.16 | 36.89% |
| 2022-12-05 | 16 | $190 | $90 | $122.642 | $91.16 | 34.53% |
| 2023-01-03 | 16 | $190 | $84 | $122.214 | $91.16 | 34.07% |
| 2023-01-17 | 16 | $190 | $84 | $121.428 | $91.16 | 33.2% |
| 2023-01-19 | 16 | $190 | $84 | $120 | $91.16 | 31.64% |
The Trend in the Analyst Price Target
Over the past 30 weeks, AMED's average price target has gone down $58.64.
AMED reports an average of 35.56% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-01 | 15 | 230 | 147 | 190.357 | 164.79 | 15.51% |
| 2022-03-15 | 15 | 230 | 160 | 192.714 | 151.63 | 27.09% |
| 2022-05-27 | 15 | 221 | 117 | 182.357 | 117.53 | 55.16% |
| 2022-07-29 | 16 | 221 | 102 | 160.133 | 119.85 | 33.61% |
| 2022-11-11 | 16 | 190 | 90 | 124.785 | 91.78 | 35.96% |
AMED Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.13 | 8 | 1 | 5 | 1 | 1 | 16 |
The Trend in the Broker Recommendations
Over the past 31 months, AMED's average broker recommendation rating worsened by 0.41.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AMED as an investment opportunity.
- In terms of how AMEDISYS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 4171.49% of that group.
- AMED has a higher average analyst price target than 4084.44% of stocks in the mid market cap category.
- AMED has a greater upside potential (average analyst target price relative to current price) than 3007.32% of stocks in the mid market cap category.
- In the context of stocks in the mid market cap category, AMEDISYS INC's variance in analysts' estimates is lower than -2700.42% of them.
Stocks similar to AMEDISYS INC in the Healthcare industry regarding analyst recommendations and price targets are CHE, SGFY, and AVAH.
View All Top Stocks by Price Target
Is AMED a Buy, Hold or Sell? See the POWR Ratings now!